Ketuo Biology: In 2025, revenue reached 366 million yuan, and net profit increased by 0.17% year-on-year.

Ketuo Life Sciences announced that in 2025, the company achieved operating income of 365.9227 million yuan, an increase of 20.85% year-on-year; net profit attributable to the company's shareholders was 94.5194 million yuan, an increase of 0.17% year-on-year. During the reporting period, the board of directors held 4 meetings to review multiple proposals and convened 3 shareholder meetings. The board of directors has four specialized committees and all are performing their duties as required. In the year 2025, the performance evaluation results of the 4 non-independent directors and 3 independent directors were all rated as "qualified". In 2026, the board of directors will enhance information disclosure, improve governance structure, and strengthen investor relations management.